Journey Medical (DERM) Change in Account Payables (2020 - 2026)

Journey Medical has reported Change in Account Payables for 7 years, with the latest figure at -$649000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 60.57% year-over-year to -$649000.0; the trailing twelve-month figure through Mar 2026 stood at -$6.2 million (down 560.49% YoY), and the FY2025 full-year result was -$7.2 million, down 242.97% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$649000.0, up from -$2.7 million in the prior quarter.
• The five-year high for Change in Account Payables was $7.1 million in Q1 2023, with the low at -$11.9 million in Q2 2023.
• Historically, Change in Account Payables has averaged -$825000.0 across 5 years, with a median of -$739000.0 in 2024.
• Annual changes were most pronounced in 2022 — Change in Account Payables surged 736.04% — and 2023, when it plunged 511.99%.
• Journey Medical's Change in Account Payables stood at $2.9 million in 2022, then tumbled by 440.18% to -$10.0 million in 2023, then jumped by 107.1% to $711000.0 in 2024, then sank by 480.59% to -$2.7 million in 2025, then soared by 76.02% to -$649000.0 in 2026.
• The last three Change in Account Payables figures came in at -$649000.0 (Q1 2026), -$2.7 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.